手足口病治疗1号方治疗手足口病邪犯肺脾证的临床研究
发布时间：2018-11-09 19:06
【摘要】：目的：观察和评价手足口病治疗1号方治疗手足口病邪犯肺脾证（轻症）的临床疗效及其安全性。 方法：本研究对符合纳入标准的患儿按1：1随机分组：试验组52例，在西医常规治疗的基础上服用手足口病治疗1号方；对照组52例，采用单纯西药常规治疗。建立临床观察表，分别治疗6天，用药期间每天观察记录患儿症状、体征改善情况，观察结束后，对各项指标进行统计学处理。 结果：本次试验试验组总有效率和愈显率分别为98.0%、94.1%，对照组则分别为96.1%、80.2%，两组比较，试验组总疗效及临床愈显率均优于对照组，u检验；试验组在减少中医症候积分，退热起效、完全退热、促进皮疹消退以及咳嗽（喘息）、咽痛、泄泻等症候的改善方面也优于对照组。 结论：手足口病治疗1号方治疗手足口病邪犯肺脾证疗效显著，能明显改善症状，缩短病程，，且无不良反应。
[Abstract]:Objective: to observe and evaluate the clinical efficacy and safety of Hand-Foot-mouth Disease (HFMD) treated with No.1 prescription in treating hand foot-mouth disease with lung and spleen syndrome (mild syndrome). Methods: according to the inclusive criteria, the children in the study were randomly divided into two groups: the experimental group (52 cases) was treated with traditional western medicine, and the control group (52 cases) was treated with routine western medicine on the basis of routine treatment of hand, foot and mouth disease. The clinical observation table was established and treated for 6 days. During the treatment period, the symptoms and signs of the children were observed and recorded daily. After the observation was finished, the indexes were treated statistically. Results: the total effective rate and the effective rate of the treatment group were 98.0 and 94.1respectively, while that of the control group were 96.1and 80.2.Compared between the two groups, the total curative effect and the clinical obvious rate of the trial group were better than those of the control group. The experimental group was also superior to the control group in reducing TCM symptom score, antipyretic effect, completely reducing fever, promoting exanthema regression and improving cough (wheezing), sore throat, diarrhea and other symptoms. Conclusion: Hand-foot-mouth disease treatment prescription No. 1 has a significant effect on treating hand foot-mouth disease evil invading lung and spleen syndrome, can obviously improve symptoms, shorten the course of disease, and have no adverse reactions.
【学位授予单位】：山东中医药大学
【学位级别】：硕士
【学位授予年份】：2012
【分类号】：R272
本文编号：2321305
[Abstract]:Objective: to observe and evaluate the clinical efficacy and safety of Hand-Foot-mouth Disease (HFMD) treated with No.1 prescription in treating hand foot-mouth disease with lung and spleen syndrome (mild syndrome). Methods: according to the inclusive criteria, the children in the study were randomly divided into two groups: the experimental group (52 cases) was treated with traditional western medicine, and the control group (52 cases) was treated with routine western medicine on the basis of routine treatment of hand, foot and mouth disease. The clinical observation table was established and treated for 6 days. During the treatment period, the symptoms and signs of the children were observed and recorded daily. After the observation was finished, the indexes were treated statistically. Results: the total effective rate and the effective rate of the treatment group were 98.0 and 94.1respectively, while that of the control group were 96.1and 80.2.Compared between the two groups, the total curative effect and the clinical obvious rate of the trial group were better than those of the control group. The experimental group was also superior to the control group in reducing TCM symptom score, antipyretic effect, completely reducing fever, promoting exanthema regression and improving cough (wheezing), sore throat, diarrhea and other symptoms. Conclusion: Hand-foot-mouth disease treatment prescription No. 1 has a significant effect on treating hand foot-mouth disease evil invading lung and spleen syndrome, can obviously improve symptoms, shorten the course of disease, and have no adverse reactions.
【学位授予单位】：山东中医药大学
【学位级别】：硕士
【学位授予年份】：2012
【分类号】：R272
【引证文献】
相关硕士学位论文 前1条
1 刘宏瑞;痰热清注射液治疗小儿手足口病的临床疗效观察[D];黑龙江中医药大学;2013年
本文编号：2321305
本文链接：https://www.wllwen.com/yixuelunwen/eklw/2321305.html
最近更新
教材专著
